CRAYON
Every story · every side  ·  est. 1995
Business

SELLAS Stock Triples on Cancer Vaccine Cutting Death Risk by 41% in Pivotal Leukemia Trial,

Photo: Benzinga
▲ Sign in to vote stories up

Coverage 1 source · 1 report

Chronological.

  1. Benzinga FIRST 1h ago SELLAS Stock Triples on Cancer Vaccine Cutting Death Risk by 41% in Pivotal Leukemia Trial,

Discussion 0 comments